HomeCompareMNTV vs MRK

MNTV vs MRK: Dividend Comparison 2026

MNTV yields 21.16% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MNTV wins by $21.6K in total portfolio value
10 years
MNTV
MNTV
● Live price
21.16%
Share price
$9.45
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.4K
Annual income
$7,616.03
Full MNTV calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MNTV vs MRK

📍 MNTV pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMNTVMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MNTV + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MNTV pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MNTV
Annual income on $10K today (after 15% tax)
$1,798.94/yr
After 10yr DRIP, annual income (after tax)
$6,473.63/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $1,854.79/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MNTV + MRK for your $10,000?

MNTV: 50%MRK: 50%
100% MRK50/50100% MNTV
Portfolio after 10yr
$67.6K
Annual income
$8,707.09/yr
Blended yield
12.88%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MNTV
Analyst Ratings
1
Buy
5
Hold
Consensus: Hold
Price Target
$7.41
-21.6% upside vs current
Range: $7.41 — $7.41
Altman Z
0.7
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MNTV buys
0
MRK buys
0
No recent congressional trades found for MNTV or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMNTVMRK
Forward yield21.16%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$78.4K$56.8K
Annual income after 10y$7,616.03$9,798.13
Total dividends collected$45.9K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy
Analyst price target$7.41$128.54

Year-by-year: MNTV vs MRK ($10,000, DRIP)

YearMNTV PortfolioMNTV Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,816$2,116.40$11,206$366.19+$1.6KMNTV
2$16,249$2,535.02$12,650$502.35+$3.6KMNTV
3$20,390$3,003.62$14,407$694.19+$6.0KMNTV
4$25,339$3,522.54$16,585$967.82+$8.8KMNTV
5$31,204$4,091.28$19,342$1,363.89+$11.9KMNTV
6$38,097$4,708.64$22,913$1,947.19+$15.2KMNTV
7$46,137$5,372.68$27,662$2,823.89+$18.5KMNTV
8$55,447$6,080.79$34,159$4,173.35+$21.3KMNTV
9$66,158$6,829.80$43,337$6,308.80+$22.8KMNTV
10$78,405$7,616.03$56,776$9,798.13+$21.6KMNTV

MNTV vs MRK: Complete Analysis 2026

MNTVStock

Momentive Global Inc. provides Software-as-a-Service solutions that help businesses turn stakeholder feedback into action in the United States and internationally. It offers survey software products under the SurveyMonkey brand, that enable customers to listen and take action on stakeholder feedback; GetFeedback CX platform, which enables companies to leverage in-the-moment customer feedback to engage and retain their customers; GetFeedback Essentials provides companies the tools to launch customer experience programs quickly by gathering feedback via email and across their websites, analyzing it in one place, and integrating with their Salesforce CRM platform; GetFeedback Pro, includes the Essentials features and adds feedback collection channels, advanced analytics, automation, and additional pre-built integrations; and GetFeedback Ultimate, comprises the GetFeedback Pro features and adds mobile apps as a feedback collection channel and enables single sign-on. The company also provides Audience panel, which enables organizations to collect and analyze real-time actionable data from targeted panelists; Purpose-built insights solutions offers a suite of solutions, such as brand and industry tracking, usage & attitudes, and concept, packaging, Ad, name, message, and logo design testing; TechValidate, a marketing content automation solution; SurveyMonkey Apply, an application management solution; and Wufoo that helps users create web and mobile forms, collect file uploads, and receive online payments. It serves financial services, internet, technology, healthcare, media and entertainment, consumer goods and retail, transportation and logistics, government agencies, manufacturing, energy, education, professional services, and non-profit organizations. The company was formerly known as SVMK Inc. and changed its name to Momentive Global Inc. in June 2021. Momentive Global Inc. was founded in 1999 and is headquartered in San Mateo, California.

Full MNTV Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MNTV vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MNTV vs SCHDMNTV vs JEPIMNTV vs OMNTV vs KOMNTV vs MAINMNTV vs JNJMNTV vs ABBVMNTV vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.